Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al
Hepatology 64 (1), 7384 (2016)
Product labeling: GI adverse reactions and delayed gastric emptying are labeled considerations for GLP-1 receptor agonists confirm details in the FDA label for your specific medicine
Collectively, Retatrutides powerful multi-receptor activity extends far beyond simple weight loss, uniquely addressing the broader metabolic, cardiovascular, and neurological components crucial for extending lifespan and enhancing overall quality of life
Common checks to discuss with your clinician include: CBC (screens for anemia) Ferritin and iron studies TSH (thyroid screening) Vitamin D Vitamin B12 Zinc is sometimes considered, but usually only if there is a clinical reason to suspect deficiency
See our compliance notice below for details